No­var­tis hands Pep­tiDream $180M up­front to ex­tend ra­dio­phar­ma dis­cov­ery pact

No­var­tis is look­ing to build on its ra­dio­phar­ma re­search ma­chin­ery.

The mak­er of Lu­tathera and Plu­vic­to has ex­pand­ed its long­stand­ing pep­tide dis­cov­ery deal with Pep­tiDream …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER